Alpha DNA Investment Management’s Silicon Laboratories SLAB Stock Holding History

Alpha DNA Investment Management’s Portfolio SLAB Stock Details SLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,385	Closed	-$541K	–	200
2022 Q3	$541K	Sell	4,385 -2,873	-40%	-$384K	0.45%	110
2022 Q2	$1.02M	Buy	+7,258	New	+$1.02M	0.87%	47
2021 Q3	–	Sell	-9,871	Closed	-$1.51M	–	141
2021 Q2	$1.51M	Buy	9,871 +5,746	+139%	+$803K	1.03%	33
2021 Q1	$581K	Sell	4,125 -1,625	-28%	-$233K	0.67%	85
2020 Q4	$732K	Buy	+5,750	New	+$648K	0.78%	57

Other funds holding SLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's SLAB Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Silicon Laboratories (SLAB) in Q4 2022, closing a stake of 4,385 shares — an estimated $541K sold.

Alpha DNA Investment Management first reported a position in SLAB in Q4 2020 and held it in 5 quarters. The position peaked at $1.51M in Q2 2021. 310 funds tracked by Wall St. Rank hold SLAB as of Q4 2022.

Alpha DNA Investment Management reported no remaining Silicon Laboratories position as of Q4 2022 after selling out during the quarter.
Alpha DNA Investment Management sold 4,385 Silicon Laboratories shares in Q4 2022, an estimated $541K.
Alpha DNA Investment Management first reported a position in Silicon Laboratories in Q4 2020 and held it in 5 quarters.
Alpha DNA Investment Management's Silicon Laboratories position peaked at $1.51M in Q2 2021.
310 funds tracked by Wall St. Rank held Silicon Laboratories as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.